The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Oncogenex

Friday Science Review: January 15, 2010

A little sunflower power to brighten up a quiet week… Understanding Cancer Therapy Resistance: A molecular contribution to resistance to cancer treatments is from the cellular protein Clusterin (CLU).   This cell survival protein is targeted by the antisense based OGX-011, one of OncoGenex Pharmaceutical’s leading compounds currently in phase 2 trials for prostate, lung and [...]

Monday Biotech Deal Review: December 21, 2009

This week’s deal review shows no signs of a holiday showdown.  In Canada, BioMS’ deal with Spectral Diagnostics was interesting as a possible indicator of more to come and internationally, 5 new pharma deals were announced this morning including a $430 million deal that OncoGenex landed from Teva joining new links between Athersys and Pfizer, Lilly and Incyte, sanofi-aventis [...]

Monday Deal Review: August 10, 2009

Considering last week was abbreviated for the August long weekend here in Canada, there’s a decent amount of activity to run through.  Check out this week’s deals

Monday Deal Review: July 27, 2009

Well, July is wrapping up with no sign of summer, or of the summer doldrums.  Read on for all the rainy-day deals we found this week

Monday Deal Review: June 29, 2009

This week’s Monday Deal Review has a full set of equity deals from shelf to launch to close, one new U.S. registration and one deregistration to match, and some ideas for what to do with your debt (!), all

Follow

Get every new post delivered to your Inbox.

Join 93 other followers